|
|
Article: Morning Alert for Avanir Pharmaceuticals.
- Article from:
- M2 Presswire
- Article date:
- April 18, 2007
CopyrightCOPYRIGHT 2007 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-18 April 2007-Biotech News: Morning Alert for Avanir Pharmaceuticals(C)1994-2007 M2 COMMUNICATIONS LTD
RDATE:18042007
Morning Alert for Avanir Pharmaceuticals (NASDAQ:AVNR)
Avanir Pharmaceuticals, together with its subsidiaries, engages in the development, acquisition, and commercialization of therapeutic products for the treatment of chronic human diseases. Its product candidates serve various therapeutic markets, including the central nervous system, cardiovascular disorders, inflammatory, and infectious diseases. The company markets FazaClo, an orally-disintegrating formulation of clozapine for the treatment of resistant ...